|
시장보고서
상품코드
2109024
오메가-3 시장 : 유형별, 유래별, 용도별, 형태별, 제조 기술별, 지역별 예측(-2031년)Omega-3 Market by Type (DHA, EPA, & ALA), Source, Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Infant Formulas, and Pet Food & Feed), Form, Manufacturing Technology, and Region - Global Forecast to 2031 |
||||||
오메가-3 시장 규모는 2026년에 48억 8,000만 달러로 추정되며, 2031년까지 연평균 복합 성장률(CAGR) 12.3%로 확대되어 87억 3,000만 달러에 이를 것으로 예측됩니다.
| 조사 범위 | |
|---|---|
| 조사 대상 기간 | 2022-2031년 |
| 기준 연도 | 2025년 |
| 예측 기간 | 2026-2031년 |
| 산정 단위 | 금액(달러) 및 킬로톤 |
| 부문 | 유형별, 유래별, 용도별, 형태별, 제조 기술별, 지역별 |
| 대상 지역 | 북미, 유럽, 아시아태평양, 남미 및 기타 지역 |
오메가-3 시장은 심혈관 건강, 인지 기능, 시력, 관절 건강 및 영유아의 뇌 발달에 있어 EPA와 DHA의 역할에 대한 인식이 높아지는 데 더해, 예방 의료 및 기능성 영양에 대한 소비자의 관심이 증가함에 힘입어 놀라운 성장세를 보이고 있습니다. 영아용 조제분유 분야에서는 인지 및 신체 발달에 있어 조기 영양의 중요성, 특히 DHA 및 기타 필수 영양소의 역할에 대한 보호자들의 인식이 높아진 데 더해, 유럽, 북미, 중국 등 지역에서 유아용 조제분유에 DHA 첨가를 의무화하거나 권장하는 규제 및 지침이 도입된 것을 배경으로 폭발적인 성장이 나타나고 있습니다. 그러나 연구 개발 활동에 따른 높은 비용과 어유 가격 변동은 오메가-3 시장의 성장에 있어 과제가 될 것으로 예측됩니다.
오메가-3 시장의 변화는 각 기업에 새로운 기회를 가져다줄 가능성이 있습니다.
오메가-3 시장은 근본적인 변화를 겪고 있으며, 기업들에게 새로운 기회가 생겨나고 있습니다. 가장 중요한 변화 중 하나는 미세조류 유래 오일이나 발효 유래 오메가-3와 같은 지속 가능한 식물성 원료로의 전환입니다. 이를 통해 어유 공급에 대한 우려가 해소될 뿐만 아니라, 비건 및 환경 의식이 높은 소비자들의 지지도 얻을 수 있습니다. 또한, 영유아용 식품에 대한 DHA 첨가 의무화나 심혈관 및 인지 기능 건강 유지 관련 표시 승인 범위 확대와 같은 규제 개정도 선진국 및 신흥 시장 모두에서 꾸준한 수요를 견인하고 있습니다. 한편, 마이크로캡슐화 등의 기술적 진보로 안정성과 풍미가 향상되어, 오메가-3를 새로운 식품 및 음료 용도에 접목하는 것이 가능해졌습니다.
용도 측면에서는 기존의 건강기능식품에 더해 의약품, 반려동물사료, 수산 양식 분야에서의 오메가-3 활용이 확대되고 있습니다. 신경계 및 심혈관계 건강을 지원하는 의약품 등급 제제의 인기가 높아지고 있을 뿐만 아니라, 고급 반려동물사료와 영양이 강화된 수산 양식용 사료도 눈부신 성장을 이루고 있습니다. 남미 및 아시아태평양에서 기능성 영양 제품의 편의성이 높은 형태(구미, 분말, RTD)에 대한 수요가 증가하고, 건강 보조제 제품에 대한 소비자 지출이 늘어나면서 이러한 동향이 시장 상황을 새롭게 바꾸고 있습니다. 조달, 제품 개발, 지속가능성 측면에서 혁신을 꾀하는 기업들은 신흥 시장에서 성장을 확실히 확보할 수 있는 호기를 맞이하고 있습니다.
영양보조식품 부문은 가장 빠르게 성장하는 부문 중 하나가 될 것으로 예측됩니다.
소비자들이 예방 의학을 더욱 중시하고, 심장, 뇌, 눈, 관절 건강 유지를 위한 간편한 해결책을 찾게 됨에 따라, 영양 보조 식품 카테고리는 오메가-3 시장의 주요 성장 동력 중 하나가 되고 있습니다. 건강 관련 표시 규정에 대한 규제 당국의 승인을 바탕으로, 보충제는 신뢰성과 편의성을 제공합니다. 또한, 소프트젤, 구미, 분말과 같은 섭취 형태의 발전으로 인해 모든 연령대의 사람들에게 매력적인 제품이 되고 있습니다. 건강에 대한 인식 제고, 고령화, 그리고 제품의 창의성이 시너지를 발휘하며, 영양 보조 식품 분야에서 오메가-3에 대한 견고하고 지속적인 수요를 견인하고 있습니다.
오메가-3의 액상 형태는 오메가-3 시장에서 더 큰 점유율을 차지할 것으로 예측됩니다.
시중에 판매되는 오메가-3의 대부분은 어유, 해조류 오일, 크릴 오일에서 유래하며, 이들은 본래 액체 상태이며 영양보충제, 유아용 조제분유, 기능성 식품, 의약품에 널리 사용되고 있습니다. 액체 형태는 더 높은 순도와 생체 이용률을 실현할 수 있을 뿐만 아니라, 소프트젤, 유화제, 영양 강화 액상 식품에 배합하기도 용이합니다. 구미, 분말, 제빵 제품으로의 용도 확대에 따라 건조 제제(분말, 마이크로캡슐화된 오메가-3)도 증가 추세에 있지만, 액체 형태는 업계 전체에서 가장 비용 효율이 높고 대량 생산이 가능하며 즉시 적용할 수 있는 상태이기 때문에 계속해서 큰 시장 점유율을 차지하고 있습니다.
에이코사펜타엔산(EPA) 부문은 현저한 성장률을 보일 것으로 예측됩니다.
EPA는 중성지방 수치 저하, 염증 억제, 심혈관 기능 전반의 개선 등 심장 건강에 유익한 것으로 밝혀졌습니다. 소비자들 사이에서 이러한 건강 효과에 대한 인식이 높아짐에 따라, EPA를 함유한 오메가-3 보충제나 강화 식품 및 음료에 대한 수요가 증가하고 있으며, 이것이 오메가-3 시장의 확대에 기여하고 있습니다.
예측 기간 동안 북미 오메가-3 시장에서 미국이 주도적인 위치를 차지할 것으로 추정됩니다.
미국은 오메가-3의 세계 최대 규모 시장 중 하나입니다. 오메가-3 제품의 다양한 건강 효과에 대한 소비자의 인식이 높아지고, 미국 시장에서 쉽게 구할 수 있다는 점 덕분에 오메가-3 기반 제품 및 보충제의 소비가 크게 증가하고 있습니다. 미국의 오메가-3 소비 패턴은 캡슐, 영양보충제, 유아용 조제분유 등의 카테고리가 주도하고 있습니다. 그러나 미국은 세계에서도 최대 규모의 소비자 시장 중 하나를 보유하고 있습니다. 최근에는 EPA/DHA(오메가-3) 원료 분야에서 제품 혁신이 급증하고 있어, 새로운 오메가-3 제품이 등장하거나 식물 유래 원료의 활용이 확대되고 있습니다. 소비자들이 해양 건강을 점점 더 중요하게 여기면서, 영양보조식품 분야에서 식물 유래 오메가-3 원료에 대한 수요가 높아지고 있습니다.
이 시장의 주요 기업으로는 BASF SE(독일), Cargill, Incorporated(미국), DSM-Firmenich(네덜란드), ADM(미국), Kerry Group plc(아일랜드), Aker BioMarine(노르웨이), Croda International PLC(영국), Corbion(네덜란드), Pelagia AS(노르웨이), KD Pharma Group SA(스위스), GC Rieber(노르웨이), Cooke Aquaculture Inc.(캐나다), GOLDEN OMEGA(칠레), Polaris(프랑스), Btsa(스페인), KinOmega Biopharm Inc.(중국), Rimfrost AS(노르웨이), Mara Renewables(캐나다), Cellana Inc.(미국), AlgaeCytes Limited(영국) 등이 있습니다.
조사 범위
본 조사 보고서에서는 오메가-3 시장을 유형(도코사헥사엔산(DHA), 에이코사펜타엔산(EPA), α-리놀렌산(ALA))별로, 원료(해양 유래(어류, 조류, 크릴, 기타 해양 자원) 및 식물 유래(견과류·종자, 식물성 기름))별로, 용도(영양 보충 식품, 기능성 식품 및 음료, 의약품, 유아용 조제분유, 반려동물사료 및 사료)별로, 형태(건조·액체), 제조 기술(정성적)(추출, 정제·정제, 농축·변환, 캡슐화·안정화, 발효·생명공학), 그리고 지역(북미, 유럽, 아시아태평양, 남미 및 기타 지역)별로 분류하고 있습니다.
본 보고서의 조사 범위에는 오메가-3 원료의 성장에 영향을 미치는 주요 요인(촉진요인, 제약 요인, 과제 및 기회 등)에 대한 상세한 정보가 포함되어 있습니다. 주요 업계 기업에 대해 철저한 분석을 수행하여, 그들의 사업, 서비스, 주요 전략, 계약, 파트너십, 합의 사항, 제품 출시, 합병·인수, 그리고 오메가-3 시장과 관련된 최근 동향에 대한 인사이트를 제공합니다. 본 보고서에서는 오메가-3 시장 생태계에서 부상하고 있는 스타트업 기업의 경쟁 분석도 다루고 있습니다. 또한, 본 조사에서는 기술 분석, 생태계 및 시장 매핑, 특허 및 규제 현황 등 업계 특유의 동향에 대해서도 다루고 있습니다.
본 보고서를 구매해야 하는 이유
본 보고서는 시장 선도 기업 및 신규 진출기업에게 오메가-3 시장 전체 및 각 하위 부문의 매출에 대한 가장 정확한 추정치를 제공합니다. 이를 통해 이해관계자는 경쟁 구도를 이해하고, 자사의 비즈니스를 더 나은 위치로 이끌며, 적절한 시장 진출 전략을 수립하기 위한 추가적인 인사이트를 얻을 수 있습니다. 또한, 본 보고서는 이해관계자가 시장 동향을 파악하는 데 도움을 주며, 주요 시장 성장 촉진요인, 억제요인, 과제 및 기회에 대한 정보를 제공합니다.
본 보고서는 다음 사항에 대한 인사이트를 제공합니다.
- 오메가-3 시장의 성장에 영향을 미치는 주요 성장 촉진요인(어유의 지속가능성에 대한 우려로 인한 미세조류 유래 오일 및 식물성 오메가-3(아마씨, 치아, 카놀라)의 채택 확대), 제약 요인(일일 권장 섭취량 및 건강 효과에 대한 소비자 인식의 불명확성), 기회(오메가-3 섭취를 위한 대체 원료 개발을 위한 연구 개발 증가), 그리고 과제(어유 가격의 현저한 변동)에 대한 분석
- 제품 개발/혁신 : 오메가-3 시장의 연구 개발 활동 및 신제품 출시에 대한 상세한 분석
- 시장 개발 : 수익성이 높은 시장에 대한 종합적인 정보 ? 본 보고서에서는 다양한 지역의 오메가-3 시장을 분석하고 있습니다
- 시장 다각화 : 오메가-3 시장의 새로운 원료 공급원, 미개척 지역, 최근 동향 및 투자에 대한 종합적인 정보
- 경쟁 분석 : BASF SE(독일), Cargill, Incorporated(미국), DSM-Firmenich(네덜란드), ADM(미국), Kerry Group plc(아일랜드), Aker BioMarine(노르웨이), Croda International PLC(영국), Corbion(네덜란드), Pelagia AS(노르웨이), KD Pharma Group SA(스위스) 및 오메가-3 시장의 기타 주요 기업에 대해 시장 점유율, 성장 전략, 제품 라인업, 브랜드·제품 비교, 제품 전개 현황에 대한 상세한 평가를 수행합니다.
자주 묻는 질문
목차
제1장 서론
제2장 주요 요약
제3장 프리미엄 인사이트
제4장 시장 개요
제5장 업계 동향
제6장 기술 진보, AI의 영향, 특허, 혁신, 향후 응용
제7장 지속가능성과 규제 상황
제8장 고객 현황과 구매 행동
제9장 오메가-3 시장(유형별)
제10장 오메가-3 시장(유래별)
제11장 오메가-3 시장(용도별)
제12장 오메가-3 시장(형태별)
제13장 오메가-3 시장(제조 기술별)
제14장 오메가-3 시장(지역별)
제15장 경쟁 구도
제16장 기업 개요
제17장 조사 방법
제18장 인접 시장 및 관련 시장
제19장 부록
KTH 26.08.20The omega-3 market is estimated to be USD 4.88 billion in 2026 and is projected to reach USD 8.73 billion by 2031, at a CAGR of 12.3%.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2022-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD) and Volume (Kiloton) |
| Segments | Type, Source, Application, Form, Manufacturing Technology, and Region |
| Regions covered | North America, Europe, Asia Pacific, South America, and RoW |
The omega-3 market is gaining significant traction, driven by the increasing recognition of the roles of EPA and DHA in cardiovascular health, cognitive function, vision, joint health, and infant brain development, as well as a growing consumer shift toward preventive healthcare and functional nutrition. The infant formula sector has witnessed explosive growth, driven by rising awareness among parents about the importance of early nutrition for cognitive and physical development, particularly the role of DHA and other essential nutrients, and regulatory mandates and recommendations in regions such as Europe, North America, and China requiring or encouraging DHA fortification in infant formula. However, high costs involved in R&D activities and unstable fish oil prices are expected to pose a challenge to the omega-3 market's growth.
Disruptions in the omega-3 market may offer opportunities for players
The omega-3 market is undergoing fundamental shifts, opening up new opportunities for companies. One of the most significant changes is the shift toward sustainable and plant-based sources such as algal oil and fermentation-based omega-3, which eliminate fish oil supply concerns and resonate with vegan and green consumers. Regulatory updates, such as the mandatory fortification of DHA in infant nutrition and broader approvals for cardiovascular and cognitive well-being claims, are also driving steady demand in both developed and emerging markets. Meanwhile, technological advances such as microencapsulation are enhancing stability and flavor, allowing omega-3 to be incorporated in new food and beverage applications.
On the application front, Omega-3 is increasingly being used in pharmaceuticals, pet food, and aquaculture, apart from conventional supplements. Pharma-grade formulations for neurological and cardiovascular health are gaining momentum, while high-end pet food and fortified aquaculture feed are experiencing significant growth. Alongside growing demand for convenience formats of functional nutrition products (gummies, powders, RTDs) and increasing consumer spending on health supplement products in South America and the Asia Pacific, these trends are redefining the landscape of the market. Players who innovate in sourcing, product development, and sustainability have a good chance of securing growth in emerging markets.
The dietary supplement segment is projected to be one of the fastest-growing segments
The dietary supplement category is one of the major growth drivers for the omega-3 market as consumers place greater emphasis on preventive healthcare and turn to convenient solutions for heart, brain, eye, and joint well-being. Supported by regulatory approvals for health claims, supplements offer confidence and convenience, as advancements in delivery forms, such as softgels, gummies, and powders, make them attractive to people of all ages. This synergy of health consciousness, aging population, and product creativity is driving robust and consistent demand for omega-3 in dietary supplements.
The liquid form of omega-3 is expected to hold a larger share of the omega-3 market
The majority of commercial omega-3 comes from fish oil, algal oil, and krill oil, which are naturally liquid forms and commonly used in dietary supplements, infant formula, functional foods, and pharmaceuticals. Liquids can accommodate higher purity, greater bioavailability, and simpler inclusion in soft gels, emulsions, and fortified liquid food. While dry formulations (powders, microencapsulated omega-3) are increasing as a result of uses in gummies, powders, and bakery applications, the liquid form continues to hold a significant market share as it is the most cost-efficient, mass-produced, and immediately applicable state across industries.
The eicosapentaenoic acid (EPA) segment is expected to grow at a significant rate
The EPA has been shown to benefit heart health, including reducing triglyceride levels, decreasing inflammation, and improving overall cardiovascular function. As awareness of these health benefits increases among consumers, there is a growing demand for omega-3 supplements and fortified foods and beverages containing EPA, which contributes to the expansion of the omega-3 market.
The US is estimated to dominate the North American omega-3 market during the forecast period
The US is one of the largest global markets for omega-3. The consumption of omega-3-based products and supplements has increased significantly due to rising consumer awareness of their various health benefits and their availability in the US market. The omega-3 consumption pattern in the US is driven toward categories such as capsules, dietary supplements, and infant formula. However, the country has one of the largest consumer markets in the world. Recently, the EPA/DHA (omega-3) ingredients sector has experienced a surge in product innovations, introducing new omega-3 variants and expanding the utilization of plant-based sources. As consumers increasingly prioritize the health of oceans, there is a growing demand for plant-based omega-3 ingredients within the dietary supplement sector.
In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the omega-3 market.
- By Company Type: Tier 1 - 30%, Tier 2 - 25%, and Tier 3 - 45%
- By Designation: CXOs - 25%, Managers - 40%, Executives - 35%
- By Region: North America - 22%, Europe - 28%, Asia Pacific - 32%, South America - 10%, and Rest of the World - 8%
Prominent companies in the market include BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega Biopharm Inc. (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), and AlgaeCytes Limited (UK).
Research Coverage
This research report categorizes the omega-3 market by type (docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and alpha-linolenic acid (ALA)), source (marine [fish, algal, krill, and other marine sources] and plant [nuts & seeds and vegetable oils]), application (dietary supplements, functional foods & beverages, pharmaceuticals, infant formulas, and pet food and feed), form (dry and liquid), manufacturing technology (qualitative) (extraction, refining & purification, concentration & conversion, encapsulation & stabilization, and fermentation & biotechnology), and region (North America, Europe, Asia Pacific, South America, and Rest of the World).
The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of omega-3 ingredients. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the omega-3 market. This report covers the competitive analysis of upcoming startups in the omega-3 market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscapes, among others.
Reasons to Buy This Report
The report offers market leaders/new entrants information on the closest approximations of the revenue numbers for the overall omega-3 and subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
- Analysis of key drivers (Rising adoption of algal oil and plant-based omega-3 (flaxseed, chia, canola) due to concerns over fish oil sustainability), restraints (lack of clarity among consumers about daily recommended intake and health claims), opportunities (increase in research for development of alternative sources to obtain omega-3), and challenges (highly unstable fish oil prices) influencing the growth of the omega-3 market
- Product Development/Innovation: Detailed insights on research & development activities and new product launches in the omega-3 market
- Market Development: Comprehensive information about lucrative markets-the report analyzes omega-3 across varied regions
- Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the omega-3 market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), and other players in the omega-3 market
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED AND REGIONS CONSIDERED
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.3.5 UNITS CONSIDERED
- 1.4 STAKEHOLDERS
- 1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
- 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS IN OMEGA-3 MARKET
- 2.4 HIGH-GROWTH SEGMENTS
- 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN OMEGA-3 MARKET
- 3.2 OMEGA-3 MARKET, BY TYPE AND REGION
- 3.3 OMEGA-3 MARKET, BY 3 TYPES
- 3.4 OMEGA-3 MARKET, BY SOURCE
- 3.5 OMEGA-3 MARKET, BY FORM
- 3.6 OMEGA-3 MARKET, BY APPLICATION
- 3.7 OMEGA-3 MARKET, BY COUNTRY
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Growing consumer awareness regarding health benefits
- 4.2.1.2 Increasing use in food and feed products
- 4.2.1.2.1 Rising demand for mother and infant nutrition products
- 4.2.1.2.2 Mandatory inclusion of algal DHA in infant formula
- 4.2.1.2.3 Growth focus of food processing companies on fortification
- 4.2.1.2.4 Increasing applications in pet food and feed
- 4.2.1.3 Shift toward pharmaceutical-grade high-concentrate omega-3 oils in developed markets
- 4.2.1.4 Emergence of innovative production technologies
- 4.2.2 RESTRAINTS
- 4.2.2.1 Declining fish oil supply due to sustainability issues in fisheries
- 4.2.2.2 Lack of clarity on daily intake recommendations and health claims
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Increasing research on alternative sources
- 4.2.3.1.1 Rising consumer demand for plant-based products
- 4.2.3.1.2 Growing focus on microalgae-based omega-3 production
- 4.2.3.1.3 Side effects and allergies related to fish-based products
- 4.2.3.2 Favorable regulatory environment
- 4.2.3.3 Integration of microencapsulation technology
- 4.2.3.1 Increasing research on alternative sources
- 4.2.4 CHALLENGES
- 4.2.4.1 High costs involved in R&D activities
- 4.2.4.2 Volatility in fish oil prices
- 4.2.4.3 Instability of omega-3 oils
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS AND WHITE SPACES
- 4.3.1 UNMET NEEDS IN THE OMEGA 3 MARKET
- 4.3.2 WHITE SPACE OPPORTUNITIES
- 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
- 4.4.1 INTERCONNECTED MARKETS
- 4.4.2 CROSS SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 BARGAINING POWER OF BUYERS
- 5.1.4 THREAT OF SUBSTITUTES
- 5.1.5 THREAT OF NEW ENTRANTS
- 5.2 MACROECONOMIC OUTLOOK
- 5.2.1 INTRODUCTION
- 5.3 MACROECONOMIC INDICATORS
- 5.3.1 SUSTAINABILITY AND CIRCULAR ECONOMY INITIATIVES
- 5.3.2 PREVENTIVE HEALTHCARE EXPENDITURE
- 5.3.3 GROWING GERIATRIC POPULATION
- 5.4 VALUE CHAIN ANALYSIS
- 5.4.1 RESEARCH AND PRODUCT DEVELOPMENT
- 5.4.2 SOURCING
- 5.4.3 PRODUCTION AND PROCESSING
- 5.4.4 DISTRIBUTION
- 5.4.5 MARKETING AND SALES
- 5.4.6 END USERS
- 5.5 ECOSYSTEM ANALYSIS
- 5.5.1 DEMAND SIDE
- 5.5.2 SUPPLY SIDE
- 5.6 PRICING ANALYSIS
- 5.6.1 INTRODUCTION
- 5.6.2 AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE
- 5.6.3 AVERAGE SELLING PRICE (ASP) TREND, BY REGION
- 5.6.4 AVERAGE SELLING PRICE (ASP) TREND, BY SOURCE
- 5.7 TRADE ANALYSIS
- 5.7.1 IMPORT ANALYSIS: OMEGA-3
- 5.7.2 EXPORT ANALYSIS: OMEGA-3
- 5.8 KEY CONFERENCES AND EVENTS, 2026-2027
- 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.10 INVESTMENT AND FUNDING SCENARIO
- 5.11 CASE STUDY ANALYSIS
- 5.11.1 MIALGAE INTRODUCED SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY
- 5.11.2 KD PHARMA GROUP: ADVANCING PHARMACEUTICAL-GRADE OMEGA-3 PURIFICATION TECHNOLOGIES
- 5.11.3 VERAMARIS: PIONEERING SUSTAINABLE OMEGA-3 SOLUTIONS IN AQUACULTURE
- 5.11.4 DSM-FIRMENICH: EXPANDING ALGAE-DERIVED DHA ACROSS LIFE-STAGE NUTRITION
- 5.11.5 AKER BIOMARINE EXPANDED EUROPEAN MARKET ACCESS THROUGH STRATEGIC DISTRIBUTION PARTNERSHIPS
- 5.12 IMPACT OF 2025 US TARIFFS - OMEGA-3 MARKET
- 5.12.1 INTRODUCTION
- 5.12.2 PRICE IMPACT ANALYSIS
- 5.12.3 IMPACT ON COUNTRIES/REGIONS
- 5.12.3.1 US
- 5.12.3.2 Europe
- 5.12.3.3 Asia Pacific
- 5.12.4 IMPACT ON END-USE INDUSTRIES
6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
- 6.1 TECHNOLOGY ANALYSIS
- 6.1.1 KEY TECHNOLOGIES
- 6.1.1.1 Molecular distillation
- 6.1.1.2 Supercritical CO2 extraction
- 6.1.1.3 Algae fermentation
- 6.1.2 COMPLEMENTARY TECHNOLOGIES
- 6.1.2.1 Stabilization & antioxidant technologies
- 6.1.2.2 Microencapsulation
- 6.1.3 ADJACENT TECHNOLOGIES
- 6.1.3.1 Precision fermentation
- 6.1.3.2 Synthetic biology & bioprocess engineering
- 6.1.4 TECHNOLOGY/PRODUCT ROADMAP
- 6.1.4.1 Short-Term | High-Purity Omega-3 Production & Stability Enhancement
- 6.1.4.2 Mid-Term | Sustainable EPA & DHA Manufacturing
- 6.1.4.3 Long-Term | Precision Nutrition & Next-Generation Omega-3 Innovation
- 6.1.1 KEY TECHNOLOGIES
- 6.2 PATENT ANALYSIS
- 6.3 FUTURE APPLICATIONS
- 6.3.1 CLINICAL NUTRITION & HEALTHY AGING: EXPANDING THE FUTURE OF OMEGA-3 APPLICATIONS
- 6.3.2 STABLE DHA-ENRICHED FUNCTIONAL FOODS: ADVANCING THE NEXT GENERATION OF OMEGA-3 NUTRITION
- 6.3.3 PLANT-BASED OMEGA-3 SUPPLEMENTATION: ENABLING THE FUTURE OF PERSONALIZED VEGAN NUTRITION
- 6.3.4 OMEGA-3 BIOMARKER-BASED PRENATAL NUTRITION: ENABLING PRECISION MATERNAL HEALTHCARE
- 6.4 IMPACT OF GENERATIVE AI ON OMEGA 3 MARKET
- 6.4.1 INTRODUCTION
- 6.4.2 TOP USE CASES AND MARKET POTENTIAL
- 6.4.3 BEST PRACTICES IN OMEGA 3 INDUSTRY
- 6.4.4 CASE STUDIES OF AI IMPLEMENTATION IN OMEGA 3 MARKET
- 6.4.5 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
- 6.4.6 CLIENTS' READINESS TO ADOPT GENERATIVE AI FOR OMEGA 3 PRODUCTION
- 6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
7 SUSTAINABILITY AND REGULATORY LANDSCAPE
- 7.1 REGIONAL REGULATIONS AND COMPLIANCE
- 7.1.1 INDUSTRY STANDARDS
- 7.1.2 LABELING REQUIREMENTS AND CLAIMS
- 7.1.3 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS
- 7.1.3.1 Enhanced Traceability and Sustainability Requirements
- 7.1.3.2 Global Harmonization of Omega-3 Labeling and Health Claims
- 7.1.3.3 Stricter Quality, Purity, and Contaminant Standards
- 7.1.3.4 Digital Traceability, AI-Enabled Quality Monitoring, and Compliance Automation
- 7.1.3.5 Stronger Sustainability and ESG Compliance Requirements
- 7.2 SUSTAINABILITY INITIATIVES
- 7.2.1 SUSTAINABLE SOURCING
- 7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES
- 7.2.3 CIRCULAR ECONOMY APPROACHES
- 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
- 7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
- 8.1 DECISION-MAKING PROCESS
- 8.2 KEY STAKEHOLDERS AND BUYING CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 BUYING CRITERIA
- 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
- 8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
- 8.5 MARKET PROFITABILITY
- 8.6 REVENUE POTENTIAL
- 8.6.1 COST DYNAMICS
9 OMEGA-3 MARKET, BY TYPE
- 9.1 INTRODUCTION
- 9.2 DOCOSAHEXAENOIC ACID
- 9.2.1 NEED FOR PROTECTION AGAINST ALZHEIMER'S DISEASE TO DRIVE DEMAND
- 9.3 EICOSAPENTAENOIC ACID
- 9.3.1 ABILITY TO REDUCE SUSCEPTIBILITY TO CARDIOVASCULAR DISEASES TO BOOST DEMAND
- 9.4 ALPHA-LINOLENIC ACID
- 9.4.1 GROWING POPULARITY AMONG VEGETARIANS AND VEGANS TO BOOST DEMAND
10 OMEGA-3 MARKET, BY SOURCE
- 10.1 INTRODUCTION
- 10.2 MARINE
- 10.2.1 NEED FOR HEALTHY FETAL DEVELOPMENT IN PREGNANT WOMEN TO DRIVE MARKET
- 10.2.2 FISH
- 10.2.2.1 Anchovy
- 10.2.2.2 Sardine
- 10.2.2.3 Mackerel
- 10.2.2.4 Other fish types
- 10.2.3 ALGAE
- 10.2.3.1 Schizochytrium sp.
- 10.2.3.2 Crypthecodinium cohnii
- 10.2.3.3 Nannochloropsis sp.
- 10.2.3.4 Other algae types
- 10.2.4 KRILL
- 10.2.5 OTHER MARINE SOURCES
- 10.3 PLANT
- 10.3.1 GROWING USE OF FLAX SEEDS FOR CANCER PREVENTION TO BOOST DEMAND
- 10.3.2 NUTS & SEEDS
- 10.3.3 VEGETABLE OILS
11 OMEGA-3 MARKET, BY APPLICATION
- 11.1 INTRODUCTION
- 11.2 DIETARY SUPPLEMENTS
- 11.2.1 GROWING IMPORTANCE OF BALANCED AND NUTRITIOUS DIETS TO DRIVE DEMAND
- 11.3 FUNCTIONAL FOODS & BEVERAGES
- 11.3.1 ABILITY TO BOOST CARDIOVASCULAR HEALTH TO DRIVE DEMAND
- 11.3.2 DAIRY & DAIRY ALTERNATIVES
- 11.3.3 BAKERY & CEREAL PRODUCTS
- 11.3.4 CONFECTIONERY PRODUCTS
- 11.3.5 MEAT & MEAT PRODUCTS
- 11.3.6 BEVERAGES
- 11.3.7 OTHER FUNCTIONAL FOOD PRODUCTS
- 11.4 PHARMACEUTICALS
- 11.4.1 GROWING NEED TO LOWER ELEVATED TRIGLYCERIDE LEVELS TO DRIVE MARKET
- 11.5 INFANT FORMULAS
- 11.5.1 RISING CONSUMPTION OF OMEGA-3 DHA DURING PREGNANCY TO BOOST DEMAND
- 11.6 PET FOOD & FEED
- 11.6.1 GREATER EMPHASIS ON ENHANCING IMMUNITY IN PETS TO DRIVE MARKET
- 11.6.2 PET FOOD
- 11.6.3 ANIMAL FEED
12 OMEGA-3 MARKET, BY FORM
- 12.1 INTRODUCTION
- 12.2 DRY
- 12.2.1 ENCAPSULATED STABILITY MEETS VERSATILE APPLICATIONS
- 12.3 LIQUID
- 12.3.1 HIGH BIOAVAILABILITY AND EFFICACY TO FUEL DEMAND
13 OMEGA 3 MARKET, BY MANUFACTURING TECHNOLOGY
- 13.1 INTRODUCTION
- 13.2 EXTRACTION
- 13.3 REFINING & PURIFICATION
- 13.4 CONCENTRATION & CONVERSION
- 13.5 ENCAPSULATION & STABILIZATION
- 13.6 FERMENTATION & BIOTECHNOLOGY
14 OMEGA-3 MARKET, BY REGION
- 14.1 INTRODUCTION
- 14.2 NORTH AMERICA
- 14.2.1 US
- 14.2.1.1 Growing incorporation of omega-3 in dietary supplements to drive market
- 14.2.2 CANADA
- 14.2.2.1 Increasing application in functional foods & beverages to boost market
- 14.2.3 MEXICO
- 14.2.3.1 Growing focus on heart disease prevention to drive market
- 14.2.1 US
- 14.3 EUROPE
- 14.3.1 GERMANY
- 14.3.1.1 Low fish consumption to boost demand for omega-3-based supplements
- 14.3.2 UK
- 14.3.2.1 Rising gastrointestinal health awareness supporting Omega-3 demand
- 14.3.3 FRANCE
- 14.3.3.1 Rising cardiovascular disease burden driving Omega-3 consumption
- 14.3.4 NORWAY
- 14.3.4.1 Production of genetically modified canola to offer lucrative growth opportunities to market players
- 14.3.5 ITALY
- 14.3.5.1 High production of dietary supplements, functional food products, and beverages to boost market
- 14.3.6 SPAIN
- 14.3.6.1 Rising consumer awareness and dietary gaps to drive market
- 14.3.7 NETHERLANDS
- 14.3.7.1 Growing incidences of depression, autism, and ADHD to drive market
- 14.3.8 REST OF EUROPE
- 14.3.1 GERMANY
- 14.4 ASIA PACIFIC
- 14.4.1 CHINA
- 14.4.1.1 Increasing focus on product innovations and diversification to drive market
- 14.4.2 INDIA
- 14.4.2.1 Growing incidences of heart failure to drive market
- 14.4.3 JAPAN
- 14.4.3.1 Rapidly aging population driving demand for Omega-3 supplements
- 14.4.4 AUSTRALIA & NEW ZEALAND
- 14.4.4.1 Government-led initiatives to increase awareness regarding omega-3 to drive market
- 14.4.5 REST OF ASIA PACIFIC
- 14.4.1 CHINA
- 14.5 SOUTH AMERICA
- 14.5.1 BRAZIL
- 14.5.1.1 Rising demand for algal oils to drive market
- 14.5.2 ARGENTINA
- 14.5.2.1 Commercialization of omega-3 products to fuel market
- 14.5.3 REST OF SOUTH AMERICA
- 14.5.1 BRAZIL
- 14.6 REST OF THE WORLD (ROW)
- 14.6.1 AFRICA
- 14.6.1.1 Prevalence of undernutrition among pregnant women and children to drive market
- 14.6.2 MIDDLE EAST
- 14.6.2.1 Ongoing innovations in omega-3 products to drive market
- 14.6.1 AFRICA
15 COMPETITIVE LANDSCAPE
- 15.1 OVERVIEW
- 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 15.3 REVENUE ANALYSIS
- 15.4 MARKET SHARE ANALYSIS
- 15.5 COMPANY VALUATION AND FINANCIAL METRICS
- 15.6 OMEGA-3 MARKET: BRAND/PRODUCT COMPARISON
- 15.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 15.7.1 STARS
- 15.7.2 EMERGING LEADERS
- 15.7.3 PERVASIVE PLAYERS
- 15.7.4 PARTICIPANTS
- 15.7.5 COMPANY FOOTPRINT: KEY PLAYERS
- 15.7.5.1 Company footprint
- 15.7.5.2 Regional footprint
- 15.7.5.3 Source footprint
- 15.7.5.4 Type footprint
- 15.7.5.5 Application footprint
- 15.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 15.8.1 PROGRESSIVE COMPANIES
- 15.8.2 RESPONSIVE COMPANIES
- 15.8.3 DYNAMIC COMPANIES
- 15.8.4 STARTING BLOCKS
- 15.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
- 15.9 COMPETITIVE SCENARIO AND TRENDS
- 15.9.1 OMEGA-3 MARKET: PRODUCT LAUNCHES
- 15.9.2 DEALS
- 15.9.3 EXPANSIONS
16 COMPANY PROFILES
- 16.1 KEY PLAYERS
- 16.1.1 DSM-FIRMENICH
- 16.1.1.1 Business overview
- 16.1.1.2 Products/Solutions/Services offered
- 16.1.1.3 Recent developments
- 16.1.1.3.1 Product launches and enhancements
- 16.1.1.4 MnM view
- 16.1.1.4.1 Key strengths
- 16.1.1.4.2 Strategic choices
- 16.1.1.4.3 Weaknesses and competitive threats
- 16.1.2 CARGILL, INCORPORATED
- 16.1.2.1 Business overview
- 16.1.2.2 Products/Solutions/Services offered
- 16.1.2.3 Recent developments
- 16.1.2.3.1 Deals
- 16.1.2.4 MnM view
- 16.1.2.4.1 Key strengths
- 16.1.2.4.2 Strategic choices
- 16.1.2.4.3 Weaknesses and competitive threats
- 16.1.3 BASF SE
- 16.1.3.1 Business overview
- 16.1.3.2 Products/Solutions/Services offered
- 16.1.3.3 Recent developments
- 16.1.3.3.1 Deals
- 16.1.3.4 MnM view
- 16.1.3.4.1 Key strengths
- 16.1.3.4.2 Strategic choices
- 16.1.3.4.3 Weaknesses and competitive threats
- 16.1.4 ADM
- 16.1.4.1 Business overview
- 16.1.4.2 Products/Solutions/Services offered
- 16.1.4.3 MnM view
- 16.1.4.3.1 Key strengths
- 16.1.4.3.2 Strategic choices
- 16.1.4.3.3 Weaknesses and competitive threats
- 16.1.5 KERRY GROUP PLC
- 16.1.5.1 Business overview
- 16.1.5.2 Products/Solutions/Services offered
- 16.1.5.3 Recent developments
- 16.1.5.3.1 Deals
- 16.1.5.4 MnM view
- 16.1.5.4.1 Key strengths
- 16.1.5.4.2 Strategic choices
- 16.1.5.4.3 Weaknesses and competitive threats
- 16.1.6 CORBION
- 16.1.6.1 Business overview
- 16.1.6.2 Products/Solutions/Services offered
- 16.1.6.3 Recent developments
- 16.1.6.3.1 Product launches and enhancements
- 16.1.6.3.2 Other developments
- 16.1.6.4 MnM view
- 16.1.7 KD PHARMA GROUP SA
- 16.1.7.1 Business overview
- 16.1.7.2 Products/Solutions/Services offered
- 16.1.7.3 Recent developments
- 16.1.7.3.1 Deals
- 16.1.7.3.2 Expansions
- 16.1.7.4 MnM view
- 16.1.8 AKER BIOMARINE
- 16.1.8.1 Business overview
- 16.1.8.2 Products/Solutions/Services offered
- 16.1.8.3 Recent developments
- 16.1.8.3.1 Product launches and enhancements
- 16.1.8.3.2 Expansions
- 16.1.8.3.3 Deals
- 16.1.8.3.4 Other developments
- 16.1.8.4 MnM view
- 16.1.9 CRODA INTERNATIONAL PLC
- 16.1.9.1 Business overview
- 16.1.9.2 Products/Solutions/Services offered
- 16.1.9.3 MnM view
- 16.1.10 EVONIK INDUSTRIES AG
- 16.1.10.1 Business overview
- 16.1.10.2 Products/Solutions/Services offered
- 16.1.10.3 Recent developments
- 16.1.10.3.1 Deals
- 16.1.10.4 MnM view
- 16.1.11 PELAGIA
- 16.1.11.1 Business overview
- 16.1.11.2 Products/Solutions/Services offered
- 16.1.11.3 Recent developments
- 16.1.11.3.1 Product launches and enhancements
- 16.1.11.3.2 Other developments
- 16.1.11.4 MnM view
- 16.1.12 GC RIEBER
- 16.1.12.1 Business overview
- 16.1.12.2 Products/Solutions/Services offered
- 16.1.12.3 Recent developments
- 16.1.12.3.1 Product launches and enhancements
- 16.1.12.3.2 Expansions
- 16.1.12.4 MnM view
- 16.1.13 COOKE AQUACULTURE INC.
- 16.1.13.1 Business overview
- 16.1.13.2 Products/Solutions/Services offered
- 16.1.13.3 Recent developments
- 16.1.13.3.1 Deals
- 16.1.13.4 MnM view
- 16.1.14 ALGISYS BIOSCIENCES, INC.
- 16.1.14.1 Business overview
- 16.1.14.2 Products/Solutions/Services offered
- 16.1.14.3 Recent developments
- 16.1.14.3.1 Other developments
- 16.1.14.4 MnM view
- 16.1.15 POLARIS
- 16.1.15.1 Business overview
- 16.1.15.2 Products/Solutions/Services offered
- 16.1.15.3 Recent developments
- 16.1.15.3.1 Product launches and enhancements
- 16.1.15.3.2 Other developments
- 16.1.15.4 MnM view
- 16.1.1 DSM-FIRMENICH
- 16.2 OTHER PLAYERS
- 16.2.1 BTSA
- 16.2.1.1 Business overview
- 16.2.1.2 Products/Solutions/Services offered
- 16.2.1.3 MnM view
- 16.2.2 NOVOSANA EUROPE B.V.
- 16.2.2.1 Business overview
- 16.2.2.2 Products/Solutions/Services offered
- 16.2.2.3 MnM view
- 16.2.3 GOLDEN OMEGA
- 16.2.3.1 Business overview
- 16.2.3.2 Products/Solutions/Services offered
- 16.2.3.3 Recent developments
- 16.2.3.3.1 Deals
- 16.2.3.4 MnM view
- 16.2.4 KINOMEGA BIOPHARM INC.
- 16.2.4.1 Business overview
- 16.2.4.2 Products/Solutions/Services offered
- 16.2.4.3 MnM view
- 16.2.5 RIMFROST AS
- 16.2.5.1 Business overview
- 16.2.5.2 Products/Solutions/Services offered
- 16.2.5.3 Recent developments
- 16.2.5.3.1 Deals
- 16.2.5.4 MnM view
- 16.2.6 ALGARITHM
- 16.2.7 SOLUTEX
- 16.2.8 CELLANA INC.
- 16.2.9 SINOMEGA BIOTECH ENGINEERING CO., LTD.
- 16.2.10 ALGAECYTES LIMITED
- 16.2.1 BTSA
17 RESEARCH METHODOLOGY
- 17.1 RESEARCH DATA
- 17.1.1 SECONDARY DATA
- 17.1.1.1 Key data from secondary sources
- 17.1.2 PRIMARY DATA
- 17.1.2.1 Key data from primary sources
- 17.1.2.2 Breakdown of primary profiles
- 17.1.2.3 Key insights from industry experts
- 17.1.1 SECONDARY DATA
- 17.2 MARKET SIZE ESTIMATION
- 17.2.1 TOP-DOWN APPROACH
- 17.2.2 SUPPLY-SIDE ANALYSIS
- 17.2.3 BOTTOM-UP APPROACH (DEMAND SIDE)
- 17.3 DATA TRIANGULATION AND MARKET BREAKUP
- 17.4 RESEARCH ASSUMPTIONS
- 17.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT
18 ADJACENT & RELATED MARKETS
- 18.1 INTRODUCTION
- 18.2 STUDY LIMITATIONS
- 18.3 FUNCTIONAL FOOD INGREDIENTS MARKET
- 18.3.1 MARKET DEFINITION
- 18.3.2 MARKET OVERVIEW
- 18.4 MARINE COLLAGEN MARKET
- 18.4.1 MARKET DEFINITION
- 18.4.2 MARKET OVERVIEW
19 APPENDIX
- 19.1 DISCUSSION GUIDE
- 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 19.3 CUSTOMIZATION OPTIONS
- 19.4 RELATED REPORTS
- 19.5 AUTHOR DETAILS
